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Summary 
Increased peripheral levels of cytokines and central microglial activation have been 
reported in patients with psychiatric disorders. The degree of both innate and adaptive 
immune activation is also associated with worse clinical outcomes and poor treatment 
response in these patients. Understanding the possible causes and mechanisms 
leading to this immune activation is therefore an important and necessary step for the 
development of novel and more effective treatment strategies for these patients. In this 
manuscript, we review the evidence of literature pointing to childhood trauma as one 
of the main causes behind the increased immune activation in patients with psychiatric 
disorders. We then discuss the potential mechanisms linking the experience of early-
life adversity (ELA) to innate immune activation. Specifically, we focus on the 
innervation of the bone marrow from sympathetic nervous system (SNS) as new and 
emerging mechanism that has the potential to bridge the observed increases in both 
central and peripheral inflammatory markers in patients exposed to ELA.  Experimental 
studies in laboratory rodents suggest that SNS activation following early-life stress 
exposure causes a shift in the profile of innate immune cells, with an increase in pro-
inflammatory monocytes. In turn, these cells traffic to the brain and influence neural 
circuitry, which manifests as increased anxiety and other relevant-behavioral 
phenotypes. To date however, very few studies have been conducted to explore this 
candidate mechanism in humans. Future research is also needed to clarify whether 
these pathways could be partially reversible to improve prevention and treatment 
strategies in the future. 
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In the past two decades, converging lines of evidence from several studies suggest a 
role for activation and/or dysfunction of the immune system in the pathogenesis of 
major psychiatric disorders such as depression and psychotic disorders. Specifically, 
there is evidence for increased peripheral immune activation, typically characterized 
by elevations in the levels of circulating pro-inflammatory cytokines such as interleukin 
(IL)-6 or IL-1. In addition, other inflammatory markers, such as C reactive protein 
(CRP) are also commonly increased in these patients. Finally, in both depression and 
psychotic disorder there is evidence from post-mortem brain tissue and in vivo 
neuroimaging studies to suggest central microglia activation, the brain’s resident 
innate immune cell, although these data are not unequivocal (1, 2). The increased 
innate immune activation in these patients may be of particular clinical relevance, 
based on the findings of our group and others that the degree of immune activation, at 
least in terms of peripheral cytokines and CRP, is associated with more severe clinical 
symptoms, suicidal ideation and poor response to treatment (2-4). 
 
In order to develop novel treatment and/or preventative measures for these patients, 
we need to better understand what are the causes and potential mechanisms 
underlying the immune activation in patients with psychiatric disorders. In this review 
we seek to address this question by first reviewing the evidence that links the 
experience of traumatic and stressful events during childhood to innate immune 
activation and development of psychopathology in later life (1). Childhood trauma is, 
unfortunately, highly prevalent in our society and one of the most widely recognized 
risk factors for development of psychiatric disorders later in life, including major 
depression, psychosis, and post-traumatic stress disorder (PTSD) (5-7). Research 
carried out in the past two decades has clearly identified a role for the activation of the 
immune system as a potential biological mechanism connecting childhood trauma and 
the subsequent development of psychopathology (8). In the second part of the 
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manuscript, we focus on the emerging evidence for a role of the sympathetic nervous 
system (SNS) as one of the main mechanisms behind the link between early life 
adversities (ELA) and peripheral and central inflammation. With this critical overview, 
the paper shows and identifies necessary next steps for research in this field, to enable 
the future development of clinical preventative and treatment strategies in victims of 
childhood trauma.  
 
2. Evidence for the association between early life adversities and activation of 
the innate immune system 
 2.1 Increased circulating cytokines and acute phase proteins 
The presence of increased immune activation in patients with psychiatric disorders 
across different diagnostic categories has generated increasing interest in unraveling 
causes behind this immune activation. In the context of peripheral immune activation, 
several clinical studies so far have shown that inflammatory markers, such as IL-6 and 
C reactive protein (CRP), are particularly high in patients who had experienced 
childhood traumatic events including physical or sexual abuse, emotional abuse or 
neglect that occur in childhood; this has been demonstrated both in patients suffering 
with psychosis, major depression or bipolar disorder (9-13). These primary research 
findings are supported by evidence from systematic reviews that provide evidence for 
prolonged peripheral inflammation following exposure to traumatic events in childhood 
(8, 11, 14). Increased levels of other peripheral circulating inflammatory markers, such 
as the acute phase protein CRP, are also widely reported in young children exposed 
to adverse psychosocial events (15, 16). Moreover, this initial early immune activation 
appears to persist and thus become chronic throughout adult life (14). In a previous 
meta-analysis, we reported evidence to suggest that adult subjects with experience of 
childhood trauma have higher levels not only of CRP, but also of the major pro-
inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α, when 
compared with adults without such experience (8).  
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One important point in this regard is that the magnitude of the increases in these 
inflammatory markers is not comparable to that found following acute infections. 
Rather, it more closely resembles a low-threshold, chronic inflammation, which is 
broadly comparable to detectable levels of these markers in patients with 
cardiovascular disease or rheumatoid arthritis. Although modest in terms of intensity, 
this persistent immune activation appears to be relevant for development of psychiatric 
disorders later on in life. Specifically, data derived from longitudinal cohorts of children 
provide evidence for statistically significant associations between experiencing 
childhood traumatic events and increases in peripheral CRP levels, which are 
particularly pronounced in those individuals who later developed depression in adult 
life (17, 18).  
 
2.2 Circulating immune cell populations – evidence for changes in both innate and 
adaptive immunity following ELA exposure 
  
In contrast to the wealth of data on circulating cytokines following early life trauma 
exposure, proportionally far fewer studies have directly investigated the effects of 
exposure to childhood adversities on circulating immune cell populations using for 
example, fluorescence activated cell sorting (FACS). In adolescents who experienced 
early life stress compared to those without such experience, do Prado and colleagues 
reported increases in circulating T-cells expressing the activation markers 
CD2+/CD4+/CD25+ and CD3+/CD69+, but also an increase in senescent T cells 
(CD8+/CD28- and CD4+/CD28- cells) (19). These changes were further accompanied 
by decreased percentages of Natural Killer (NK; CD3-/CD56+) and NK T-cells 
(CD3+/CD56+) (19). Comparing individuals separated from their mothers in early life to 
those reared by their parents, Elwenspoek and colleagues also reported increased T-
cell senescence (CD57+ cells) (20). In another FACS study from this group, comparing 
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individuals with a history of ELA with those without, a reduction in the numbers of 
CD69+/CD8+ T-cells and increased numbers of HLA-DR+/CD4+, HLA-DR+/CD8+ and 
CD25+/CD8+ T-cells was reported (21). Collectively, these results suggest that ELA 
exposure is associated with a sustained activation of adaptive immunity and 
accelerated immune ageing, as indexed by the increase in T-cell senescence. These 
effects appeared to be independent of either stress or health-risk behaviours, 
suggestive of a primary effect of early-life programming on specific immune cell 
populations (20-22). Exploring how social adversity may affect peripheral immune 
cells, Counotte et al. (2018) observed that individuals with high clinical risk for 
psychosis who were exposed to ELA were characterized by an increased number of 
CD4+ T-helper (Th) 17 cells when compared with those at lower risk (23). There were 
also significant predictive relationships between increased numbers of T regulator (T-
reg) cells and decreased NK cell numbers, with the increased degree of stress 
experienced during exposure to virtual social stressors (23). If and how these different 
associations fit together still needs to be elucidated. Other studies characterizing the 
effects of social adversities on peripheral leukocyte populations have mainly identified 
increases in circulating monocytes and dendritic cells following exposure to traumatic 
experiences in early life (24, 25). Furthermore, Schwaiger and colleagues identified an 
altered stress-induced gene expression in CD14+ monocytes of adults with history of 
childhood trauma; the differences were particularly linked to the expression of genes 
involved in steroid hormone activity and signal transduction which were in turn 
associated with increased activity of pro-inflammatory signaling upstream (26).  
 
These clinical data are supported by a large body of evidence from pre-clinical studies 
in adult mice exposed to repeated social defeat (RSD), which results in a significant 
accumulation of neutrophils and CD11b+ LyC6Hi monocytes in both the circulation and 
spleen (27, 28). Splenic dendritic cells (DCs) from mice exposed to RSD also have 
increased surface expression of MHC-I, CD80 and CD44 indicative of an activated 
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state (29). It should also be noted however, that CD44 is commonly used as a T cell 
activation marker (29). Furthermore, following in vitro stimulation, these cells display 
an up-regulated pro-inflammatory gene expression signature and produce 
comparatively higher levels of pro- and anti-inflammatory cytokines including IL-6, 
TNF- and IL-10 (29). Extending these findings, exposure to RSD in mice and low 
socioeconomic status (SES) in humans, results in a relative expansion of a 
transcriptional profile associated with immature pro-inflammatory monocytes in 
peripheral blood mononuclear cells (PMBCs) (30). This is characterized (at least in the 
mouse) by increased activity of transcription factors that regulate both differentiation 
to the myeloid lineage but also pro-inflammatory effector functions of these cells, such 
as PU.1 (30). In addition, exposure to RSD in mice results in increased formation of 
Ly6CHigh monocytes, which could be prevented using -adrenoreceptor antagonists 
(30). Collectively, these data suggest a role for the sympathetic nervous system 
driving, at least in part, up-regulation of myelopoiesis, characterized by a pro-
inflammatory state, which we will return to later in this review (30). Data on the effects 
of social stress on adaptive immunity in pre-clinical models is less developed, although 
there are data suggesting a reduction in the numbers of T-cells in the circulation and 
spleen (27, 28), which is at odds with some of the aforementioned clinical findings. On 
the other hand, RSD is reported to result in enhanced CD4+ and CD8+ memory T cell 
responses when this stress is experienced before a viral infection (31-33). These data 
suggest a view that exposure to RSD in adult mice may significantly enhance virus-
specific immune memory through the augmentation of specific memory T cell 
populations (31-33).  Interestingly, using a mediation analysis, Elwenspoek and 
colleagues found that cytomegalovirus (CMV) infection largely explained the increase 
in T-cell senescence markers (CD57+) following ELA exposure, suggesting that viral 
infections may affect T-cell populations in humans following ELA exposure (20). When 
comparing these data it should however be remembered that the great majority of pre-
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clinical studies that have characterized the peripheral immune response to stress 
exposure, have primarily focused on the effects of repeated social defeat stress (RSD) 
exposure in adult animals. Detailed peripheral immunophenotyping data regarding the 
specific effects of early-life stress in pre-clinical models is however, currently lacking. 
Another important point is that the effects of any experimental stress paradigm in 
animals may have both common and distinct effects on the immune system depending 
on the nature and duration of the stressor (34-36). In this context however, pre-clinical 
studies could be immensely valuable, since they allow the experimenter to probe the 
effects of different types of early-life stress with a precise control of genetic and other 
environmental variables, something that is very challenging in humans. Pre-clinical 
studies therefore have the clear potential to help dissect the specific peripheral 
immune cell responses associated with exposure to different stressors at different 
vulnerable periods from the prenatal period, through early postnatal life and into 
adolescence. 
 
Overall, the evidence from the few studies available suggests that ELA exposure is 
associated with (1) direct programming of innate and adaptive immune cell function; 
(2) increased numbers of circulating innate and adaptive immune cells with a pro-
inflammatory phenotype, a finding consistent with the elevation in circulating pro-
inflammatory cytokines and acute phase proteins in those exposed to ELA and (3) 
accelerated immune ageing as indicated by T-cell senescence. What remains unclear 
from these data however is whether these peripheral changes are related to central 
immune activation. Here again, studies pre-clinical models of stress exposure are vital, 
since they permit invasive assessments in both the brain and periphery to aid 
dissection of the mechanisms governing immune-to-brain communication and vice-
versa (37, 38). However, in addressing this question, we must first consider the clinical 
evidence base for central immune activation as a function of ELA exposure. 
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2.3 Central immune activation following ELA exposure 
Assessment of central immune activation in clinical samples is typically achieved 
through post-mortem neuropathological assessment at either the cellular or molecular 
level, or in vivo, using positron emission tomography (PET) combined with selective 
radioligands for the translocator protein (TSPO) comparing patient groups with healthy 
age/sex matched controls (37). Searching the extant literature, we found only one 
TSPO PET study which had tested for an association between psychosocial risk 
factors for psychosis, including childhood trauma and central TSPO radioligand 
binding. Dahoun and colleagues measured TSPO binding in a small sample of healthy 
individuals who were classified into two groups on the basis of exposure to 
psychosocial risk (high-risk group; n=12) or no significant exposure to psychosocial 
risk (low-risk group; n=12) (39). There were however no significant group differences 
however in TSPO volume of distribution (VT) in either total gray matter or the frontal, 
parietal, temporal and occipital lobes (39). At first glance, these data are not consistent 
with the hypothesis that exposure to stress and/or ELA is associated with increased 
central microglial activation. It should be noted however, that these were healthy 
individuals without a psychiatric diagnosis, raising this possibility that the “high-risk” 
group in this case are a resilient group in whom putative central microglial activation 
may not be seen (39). Moreover, although some of the stressors assessed in these 
individuals occurred recently there was a temporal separation between stress 
exposure and TSPO PET imaging. Hence, it remains possible that acute stress 
exposure could be associated with increased TSPO, which may normalize over time 
(39). Further studies are clearly required to address these issues and explore in more 
detail the effect of ELA on central TSPO binding in both pre-clinical models and clinical 
populations. In contrast, several TSPO PET studies have been conducted to search 
for any evidence of central immune activation in the psychiatric disorders for which 
ELA is a known risk factor, such as schizophrenia and depression. The data published 
so far suggest that there is evidence for putative central innate immune activation 
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associated with psychiatric disorders for which ELA exposure is a known risk factor 
(37), but evidence for specific effects of ELA on central immune cells in humans is 
currently lacking. Hence, to address this question, we must consider the evidence from 
pre-clinical rodent models of ELA exposure. 
 
Exposing rodents or non-human primates to early life stress increases anxiety-like 
behaviors and impairs cognitive function in adulthood, suggesting that animal models 
may provide important insights into the effects of ELA in humans (40-42). As 
mentioned already, it should be remembered when comparing data from pre-clinical 
models to clinical studies that the effects of any experimental stress paradigm in 
animals may have both common and distinct effects on the immune system depending 
on the nature and duration of the stressor. This is no less true for central immune 
activation following stress exposure in rodents (36, 37). Interestingly, genetically 
controlled depletion of brain microglia in healthy rodents in early life is associated with 
abnormal social and motivated behaviour in a sex-specific manner, strongly implicating 
that microglia play a role in the early life programming of behaviour (43, 44). With 
regard to the evidence that early life stress exposure influences central microglia, 
several pre-clinical studies in different early-life stress models provide converging lines 
of evidence for increased innate immune activation in the central nervous system 
(CNS). Prenatal stress exposure, induced by exposing pregnant rat dams to restraint 
or other physical stressors, is reported to increase the number of Iba1+/CD68+ 
microglia, coupled with a shift their morphology to an activated, amoeboid state and 
decreased process motility, as well as increase pro-inflammatory cytokine expression 
in the brains of the affected offspring early in post-natal life primarily (but not 
exclusively) in the hippocampus, amygdala and pre-frontal cortex (45-54). None of 
these studies however, have investigated the effects of ELA exposure on TSPO 
binding, limiting cross-species comparisons to humans. At the molecular level, 
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Delpech and colleagues have examined the effect of brief daily separation (BDS) 
stress on the microglial transcriptome in the affected offspring, providing evidence that 
this early life stress actually perturbs the normal functional development of microglial 
in the developing hippocampus, with these cells displaying increased phagocytic 
activity and reduced expression of genes that normally increase across development 
(55). It is increasingly appreciated that microglia cells play critical roles in shaping the 
process of synaptic maturation as well as axonal guidance in the developing and 
maturing brain (56-64). Hence, any stress-induced perturbation of microglial 
physiology during these critical developmental windows would be predicted to result in 
the defective maturation of neural circuits (56, 57, 65). This could have long-lasting 
consequences on synaptic function and may be another mechanism whereby 
activation of central innate immunity after ELA exposure may directly increase the 
vulnerability to develop psychopathology in later life. These cells however may also 
play a role in central to peripheral immune communication as we discuss in the next 
section. 
 
3. How does ELA lead to immune activation? 
Although both clinical and pre-clinical studies provide converging lines evidence for 
both central and peripheral immune activation following ELA exposure (notably for both 
innate and adaptive immunity), a critical question remains as to how does ELA 
exposure specifically trigger both central and peripheral inflammation? Although the 
precise mechanisms by which peripheral immunity may influence central immunity and 
neuronal function (and vice versa) remain largely unknown, a number of interesting 
candidate mechanisms have been advanced. These include, 1) the development of 
glucocorticoid resistance and therefore an impairment in the anti-inflammatory action 
of glucocorticoids; 2) the activation of the sympathetic nervous system (SNS); 3) a 
change in the composition of gut microbiota, 4) exposure to physical injuries or 
infection as part of the early life trauma and 5) behavioral mechanisms, including 
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obesity, alcohol consumption and poor sleep which may themselves promote immune 
activation (66). For the purposes of this concise review, we will focus on the link 
between SNS activation in response to stress exposure and immune activation, for 
which there is a recent increasing body of evidence (67).  
 
3.1 The role of the sympathetic nervous system in the link between early adversities 
and immune activation 
The sympathetic nervous system (SNS) is one of the main biological systems involved 
in the stress response. Its activation also results in cascade of signals, which affect the 
regulation of the innate immune system, which occurs in cell-state and organ-specific 
manner. Of particular interest however is the bone marrow (BM), which is densely 
innervated by the SNS (68). The activation of the SNS, in response to stress, for 
example, leads to the production and release of norepinephrine (NE), which binds to 
β-adrenergic (βAR) and α-adrenergic (AR) receptors expressed on peripheral 
immune cell populations in both rodents and humans (68, 69). Pre-clinical studies in 
animals show that SNS activation and NE production triggers the release of monocytes 
into the circulation, which can be modulated pharmacologically by systemic 
administration of either a β2AR agonist (increase) or βAR antagonist (decrease) (27, 
30, 32). Increased numbers of circulating monocytes is also correlated with oscillations 
in SNS tone as a function of circadian rhythm (70) and can occur following other forms 
of SNS stimuli, such as exercise (71). These observations are also true for 
lymphocytes, with exposure to acute stress in humans resulting in mobilization of total 
monocytes and lymphocytes and CD8+ T lymphocytes (71). Nor-epinephrine (NE) 
released during SNS activation may however lead to different immunomodulatory 
effects, depending on the cell type, state and organ involved. For example, Case and 
Zimmerman (2016) propose a model in which NE release can either have a 
suppressive effect on naïve T-lymphocytes in lymphoid organs such as the spleen, but 
in other regions, such as the vasculature and renal system, NE may drive the activation 
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of pro-inflammatory Th17 T-lymphocytes (72).  
 
Taken together, the aforementioned lines of evidence clearly show that SNS activation 
is well placed to mediate both innate and adaptive immunity and brain-immune 
communication, across species. There are however, no studies in healthy humans, 
either alone or in comparison to clinical populations, that provide direct evidence for a 
link between ELA exposure, SNS activation and elevated peripheral and central 
immunity, beyond the observations that stress-exposed individuals who have 
developed psychopathology have elevated numbers of circulating pro-inflammatory 
monocytes and lymphocytes – as already evidenced in this review. Here again, we 
must therefore turn to pre-clinical studies in rodent models to dissect this mechanism.   
 
As already stated, the SNS innervates peripheral lymphoid tissues including the spleen 
and bone marrow. Pre-clinical data suggest that chronic stress exposure is associated 
with a decrease in expression of the chemokine CXCL12 in the hematopoietic stem 
cell niche, which in turn accelerates proliferation of hematopoietic stem cells resulting 
in enhanced production of neutrophils and monocytes (73). Increases in SNS outflow 
and NE release following RDS exposure also drives mobilization of lymphocytes from 
the murine spleen and bone marrow, which then enter the circulation (27, 28, 30, 32, 
71, 74, 75). These data are consistent with the aforementioned findings in humans of 
increased number of leukocytes in the circulation of individuals with stress-related 
psychiatric disorders (76) and the aforementioned studies reported increases in these 
cells in the circulation of individuals exposed to ELA. The specific contribution of the 
rodent models however has been to demonstrate elegantly a potential connection 
between central and peripheral immunity, which highlights the involvement of the SNS. 
Specifically, RDS in adult mice, increases neural activation, (indexed by increased 
immunostaining for the immediate early gene c-Fos), in mouse brain regions that 
regulate fear and threat sensing, such as the amygdala, which in turn is associated 
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with both social avoidance and anxiety-like behaviour, that is sensitive to AR 
antagonism, suggesting SNS involvement downstream of the activation of neural 
stress circuitry (75). In parallel, to this increased neural activity, RDS results in central 
microglial activation, with increased density of amoeboid microglia in the amygdala, 
PFC and hippocampus, with higher surface expression of CD68, CD14 and TLR-4, 
and increased expression of both IL-1 and glucocorticoid responsive genes (e.g. 
FKBP5) in these microglia, indicative of activation (67, 74, 75, 77, 78). Moreover, 
CD11b+CD45HighLy6CHigh macrophages increased in the circulation, but also trafficked 
into the mouse brain, where they express higher amounts of IL-1 and adopt a pro-
inflammatory phenotype (see Figure 1) (67, 74, 75, 77, 78). These effects are 
dependent on AR, since they may be blocked by propranolol (a AR antagonist), 
suggestive of a role for SNS activation in the initial mobilization of the monocytes (75). 
Consistent with this view, the trafficking of monocytes from the spleen to the brain is 
necessary for the re-establishment of anxiety in stress-sensitized mice and this also 
occurs downstream of SNS activation (74, 79). Depletion of central microglia also 
prevents monocyte trafficking to the brain and blocks the development of anxiety 
behaviour developing following repeated RDS exposure (77). These data suggest a 
model in which stress exposure results in the elevated neural activity in stress circuits, 
leading to increased SNS outflow. The former triggers a microglial response, the latter 
triggers the mobilization of pro-inflammatory monocyte derived macrophages, which 
subsequently traffic to the brain in a CCR2 and IL-1-dependent manner involving 
communication between central microglia and the endothelial cells of the blood-brain 
barrier (38, 67, 80, 81). These elegant studies demonstrate a potential pathway by 
which SNS activation is a key part of a larger multi-faceted interaction between central 
neural activity in specific circuits, central microglial activation and mobilization of 
peripheral immunity, which then traffics to the brain to close the loop by influencing 




It is worth emphasizing again here that this model has been developed based on 
experiments conducted in adult animals and in the context of the RDS paradigm. 
Hence, two important pre-clinical extensions of this work are necessary. First, to 
confirm whether this mechanism is necessary and sufficient for the development of 
abnormal behaviour (such as anxiety) following exposure to other types of stressor, 
including social isolation (SI), repeated social defeat stress (RSDS) or chronic 
unpredictable mild stress (CUMS). In this context, exposure to chronic variable stress 
is reported to increase Lin−Sca-1+c-Kit+ hematopoietic stem cells in the BM (73). 
Moreover, in mice susceptible to RSDS, elevated peripheral IL-6 and increased 
circulating pro-inflammatory Ly6CHi monocytes are reported, which also traffic to the 
perivascular space to increase central IL-6 leading to depressive-like behaviour (80). 
Lastly, as already described herein, there is also evidence for central microglial 
activation in several animal models of early-life stress, although forward translation of 
this evidence to humans using TSPO binding for example is currently lacking (39). 
These data may suggest that there are indeed common mechanisms across different 
stress exposures, but further work is needed in this respect to clarify this 
mechanistically. Second, studies in the pre-, perinatal and adolescent period are 
necessary to directly test if the model proposed from adult animals contributes to the 
association between ELA exposure and psychopathology in later life. It is worth 
recalling here that microglia depletion by itself in this period (without stress exposure) 
was sufficient to induce long-term emotional behavioral changes in mice (43). 
Moreover, molecular studies suggest that microglia development may be abnormal 
following ELA exposure, perhaps indicative of later loss-of-function, or reduced 
flexibility of these cells (55, 82). Hence, the relationships between neural circuit activity 
central and peripheral immunity may differ in the developing as compared to the adult 
brain, which requires investigation (82, 83). 
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From the clinical perspective, direct evidence for involvement of the SNS per se 
following ELA exposure, still needs to be provided. Indeed, the evidence supporting 
the link between childhood trauma, for example and hyper-activation of the SNS in 
humans is conflicting, with some studies reporting an increased reactivity of SNS 
following high levels of family adversities, while others finding no such association (84). 
For example, no study has so far investigated immune markers together with markers 
of SNS activation in individuals with experience of childhood trauma compared with 
relevant controls. This would be an extremely important step to understand if the 
immune activation is found mainly in those who present an enhanced reactivity of the 
SNS. 
 
4. Conclusions  
In conclusion, increasing evidence points towards a fundamental role of ELA exposure 
in the activation of both innate and adaptive arms of the immune system in patients 
with psychiatric disorders. The SNS appears to play a central role in this link by 
increasing the activation of T cells and shifting the differentiation of hematopoietic stem 
cells in the bone marrow to pro-inflammatory monocytes, with elevated expression of 
pro-inflammatory molecules. Pre-clinical studies in adult animals suggest trafficking of 
peripheral immune cells to the brain is an important mechanism for the development 
of anxiety following stress exposure. We highlight an important lack of studies 
addressing these issues, insofar as it is possible to do so in human samples, but also 
the lack of detailed work on these potential mechanisms which link central and 
peripheral immunity following early-life stress exposure in pre-clinical models. Future 
studies to address these questions have the potential to identify molecular targets and 
time windows of opportunity for both prevention and treatment strategies to ameliorate 




Dr Mondelli is supported by MQ: Transforming Mental Health (Grant: MQBF1), the 
Medical Research Foundation (Grant: MRF-160-0005-ELP-MONDE), and the National 
Institute for Health Research (NIHR) Biomedical Research Centre at South London 
and Maudsley NHS Foundation Trust and King’s College London. The views 
expressed are those of the authors and not necessarily those of the NHS, the NIHR, 
or the Department of Health. Dr Vernon acknowledges the financial support of the 
Medical Research Council (New Investigator Research Grant MR/N025377/1 and 
Centre Grant MR/N026063/1). The authors are also supported by the King’s Together 
Fund of King’s College London. 
 
Conflict of Interest 
Dr Mondelli has received research funding from Johnson & Johnson as part of a 
research program on depression and inflammation. Dr Vernon has received research 
funding from F. Hoffman La Roche Ltd and UBC Biopharma SPRL as part of a 
research program on early life immune activation. The views expressed are those of 
the authors and not necessarily those of Johnson & Johnson, F Hoffman La Roche or 
UCB Biopharma SPRL. These funders had no influence on the decision to publish this 
work. 
 
Legend to Figures 
Figure 1: A schematic representation of how Early Life Adversities may contribute to 
peripheral and central immune activation through activation of the sympathetic nervous 
system (SNS). Orange arrows indicate neural pathways, blue indicate central 
microglial effects and green the influence of peripheral monocytes. (1) Exposure to 
early life adversity (ELA) such as childhood trauma results in (2) activation of the brain 
stress circuitry and (3) increased outflow of the sympathetic nervous system to the 
bone marrow with increased nor-epinephrine (NE) release. (4) This decreases the 
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expression of the chemokine CXCL12 in the bone marrow hematopoietic stem cell 
niche, which accelerates proliferation of hematopoietic stem cells resulting in 
enhanced production of pro-inflammatory CD14+/CD16- monocytes, which are 
released into circulation and (5) traffic to the blood-brain-barrier through the 
vasculature. (6) At the same time, central microglial cells are also activated in response 
to neural cues as a result of stress circuit activation. These cells facilitate the infiltration 
of the peripheral monocytes through secretion of specific cytokines and chemokines, 
which modulate endothelial cell permeability and allow ingress of the monocytes from 
the vasculature to the peri-vascular space and the brain parenchyma. (7) The 
infiltrating pro-inflammatory monocytes lead to further sustained activation of neural 
stress circuits, resulting in the emergence of abnormal behaviour. (8) In parallel, ELA 
exposure may also influence the development and function of central microglia. 
Converging lines of evidence suggest that microglia play key roles in shaping the 
development of the brain including the formation and pruning of dendritic spines and 
synapses. Hence, any disruption of this process following stress exposure in early life 
may result in the abnormal neural circuit development, which by itself may predispose 
an individual to psychopathology in later life. PFC: prefrontal cortex; AMYG: amygdala; 
HPC: hippocampus; NE: norepinephrine; SNS: sympathetic nervous system.  
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